Interim efficacy and safety analysis of the regimen containing delamanid in the treatment of multidrug resistant/rifampicin-resistant/extensively drug-resistant tuberculosis: a single-arm, prospective, monocentric, observational study
It registered in ICH GCP-US Clinical Trials Registry and the registration number is NCT04421495 and date of registration was June 9, 2020.
Authors
- Yuanyuan Chen (ORCID: https://orcid.org/0000-0001-5894-7836)
- Qin Yao (ORCID: https://orcid.org/0000-0003-4485-4545)
- Qingshan Cai
Institutions
- Hangzhou Red Cross Hospital (CN)
Publication Details
- Journal
- BMC Infectious Diseases
- Published
- 2025-12-19
- DOI
- https://doi.org/10.1186/s12879-025-11945-9
- Primary Topic
- Tuberculosis Research and Epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 0.00